Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism FabI inhibitors(enoyl-ACP reductase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gram-Negative Bacterial Infections | Preclinical | United States | 09 Jun 2012 | |
Mycobacterium Infections | Preclinical | United States | 09 Jun 2012 |